Drug intelligence / Profile preview

VRC-FLUDNA082-00-VP

Development stage
Unknown
Lead developer
Vaccine Research Center
Modality
Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intramuscular
01

Overview

VRC-FLUDNA082-00-VP is an investigational DNA plasmid vaccine developed by the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID). It is designed to elicit an immune response against the H2N2 subtype of the Influenza A virus. The vaccine contains a DNA plasmid encoding the hemagglutinin (HA) protein from the A/Singapore/1/1957 (H2N2) strain. In clinical development, it has been evaluated in prime-boost regimens, often serving as the priming agent followed by a boost with a ferritin-based nanoparticle vaccine (such as VRC-FLUNPF081-00-VP) to induce broader and more potent neutralizing antibody responses against H2 influenza viruses.

Other names
H2N2 influenza DNA vaccineH-2N2 influenza DNA vaccineH 2N2 influenza DNA vaccineA/Singapore/1/1957 HA DNA vaccine
02

Targets

HA (Influenza A virus hemagglutinin (A/Singapore/1/1957))HA (Hemagglutinin)

Beyond the preview

Go deeper on VRC-FLUDNA082-00-VP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VRC-FLUDNA082-00-VP.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call